Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8293520rdf:typepubmed:Citationlld:pubmed
pubmed-article:8293520lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8293520lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:8293520lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8293520lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:8293520lifeskim:mentionsumls-concept:C0302923lld:lifeskim
pubmed-article:8293520lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:8293520pubmed:issue11lld:pubmed
pubmed-article:8293520pubmed:dateCreated1994-3-3lld:pubmed
pubmed-article:8293520pubmed:abstractTextSome (piperidinomethylene)bis(phosphonic acid) derivatives were prepared and their activity to inhibit a rise in serum calcium induced by parathyroid hormone in thyroparathyroidectomised rats was evaluated. Several (4-alkylidene-, 4,4-dialkyl-, or 4-alkyl-4-halopiperidinomethylene)bis(phosphonic acid) derivatives showed considerable inhibitory activity. But compounds having aromatic and polar substituents such as azido, hydroxy, amino and amido on the piperidine ring were generally inactive. In this study, two 4-alkylidene compounds (8a and 8b) and a 4,4-cyclic dialkyl compound (61) showed potent activity when administered either intravenously or perorally.lld:pubmed
pubmed-article:8293520pubmed:languageenglld:pubmed
pubmed-article:8293520pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8293520pubmed:citationSubsetIMlld:pubmed
pubmed-article:8293520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8293520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8293520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8293520pubmed:statusMEDLINElld:pubmed
pubmed-article:8293520pubmed:monthNovlld:pubmed
pubmed-article:8293520pubmed:issn0009-2363lld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:TamuraMMlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:IkegamiSSlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:MALZS SSSlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:NomiyamaKKlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:MimuraMMlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:OhishiYYlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:HiyamaYYlld:pubmed
pubmed-article:8293520pubmed:authorpubmed-author:HayashidaMMlld:pubmed
pubmed-article:8293520pubmed:issnTypePrintlld:pubmed
pubmed-article:8293520pubmed:volume41lld:pubmed
pubmed-article:8293520pubmed:ownerNLMlld:pubmed
pubmed-article:8293520pubmed:authorsCompleteYlld:pubmed
pubmed-article:8293520pubmed:pagination1971-86lld:pubmed
pubmed-article:8293520pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:meshHeadingpubmed-meshheading:8293520-...lld:pubmed
pubmed-article:8293520pubmed:year1993lld:pubmed
pubmed-article:8293520pubmed:articleTitleSynthesis and evaluation of (piperidinomethylene)bis(phosphonic acid) derivatives as anti-osteoporosis agents.lld:pubmed
pubmed-article:8293520pubmed:affiliationCentral Research Institute, Kaken Pharmaceutical Co., Ltd., Kyoto, Japan.lld:pubmed
pubmed-article:8293520pubmed:publicationTypeJournal Articlelld:pubmed